2005
DOI: 10.1186/1471-2210-5-14
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Background: Antimuscarinic agents are the most popular treatment for overactive bladder and their efficacy in man is well documented, producing decreased urinary frequency and an increase in bladder capacity. During cystometry in rats, however, the main effect reported after acute treatment with antimuscarinics is a decrease in peak micturition pressure together with little or no effect on bladder capacity. In the present experiments we studied the effects, in rats, of the two most widely used antimuscarinic d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(7 citation statements)
references
References 39 publications
(40 reference statements)
0
7
0
Order By: Relevance
“…One of the strategies implemented to increase the number of donor organs and reduce wait times is the use of extended criteria organs of which steatotic livers comprise a major proportion. [4][5][6] Unfortunately, transplanted steatotic livers are more prone to ischemia reperfusion injury (IRI) when compared to non-steatotic livers, and also exhibit higher rates of allograft dysfunction and reduced overall survival. 7 Hepatic steatosis, however, is not always a contraindicator for transplantation.…”
Section: Introductionmentioning
confidence: 99%
“…One of the strategies implemented to increase the number of donor organs and reduce wait times is the use of extended criteria organs of which steatotic livers comprise a major proportion. [4][5][6] Unfortunately, transplanted steatotic livers are more prone to ischemia reperfusion injury (IRI) when compared to non-steatotic livers, and also exhibit higher rates of allograft dysfunction and reduced overall survival. 7 Hepatic steatosis, however, is not always a contraindicator for transplantation.…”
Section: Introductionmentioning
confidence: 99%
“…However, at higher doses oxybutynin is known to cross the blood brain barrier ( Todorova et al, 2001 ; Callegari et al, 2011 ), causing unwanted cognitive effects such as headache, somnolence, dizziness, confusion, and memory impairment ( Katz et al, 1998 ; Chancellor et al, 2012 ). Therefore, we selected a dose of 10 mg/kg based on previous rodent literature that was known to maximize effects on urinary behavior, while minimizing effects on cognition ( Oka et al, 2001 ; Angelico et al, 2005 ; Aizawa et al, 2012 ; Wada et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…We surveyed several rodent studies using oxybutynin ( Oka et al, 2001 ; Angelico et al, 2005 ; Aizawa et al, 2012 ; Wada et al, 2017 ), prazosin ( Lê et al, 2011 ; Verplaetse et al, 2012 ; Do Monte et al, 2013 ), and duloxetine ( Molteni et al, 2009 ; Miyazaki and Yamamoto, 2012 ; Di Cesare Mannelli et al, 2017 ; Pérez et al, 2018 ; Yoneda et al, 2020 ) to determine appropriate dosage. Doses were selected based on reported ranges that produced intended pharmacological effects but were below levels found to cause analogous unwanted effects observed in clinical use.…”
Section: Methodsmentioning
confidence: 99%
“…Additionally this technique of conscious restrained cystometry has been utilized successfully in our lab as well as by others to study bladder function. 10,1921 …”
Section: Discussionmentioning
confidence: 99%